Moleculin Biotech Cash from Investing (TTM) Analysis

Moleculin Biotech Inc (MBRX)

4.425 -0.18 (-3.80%) USD | NASDAQ | Apr 24, 16:00

4.29 -0.14 (-3.05%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	-0.124M
September 30, 2023	-0.043M
June 30, 2023	-0.015M
March 31, 2023	-0.061M
December 31, 2022	-0.067M
September 30, 2022	-0.086M
June 30, 2022	-0.086M
March 31, 2022	-0.025M
December 31, 2021	-0.019M
September 30, 2021	-0.014M
June 30, 2021	-0.354M
March 31, 2021	-0.372M
December 31, 2020	-0.374M
September 30, 2020	-0.369M
June 30, 2020	-0.037M

Date	Value
March 31, 2020	-0.038M
December 31, 2019	-0.051M
September 30, 2019	-0.156M
June 30, 2019	-0.443M
March 31, 2019	-0.424M
December 31, 2018	-0.417M
September 30, 2018	-0.319M
June 30, 2018	-0.032M
March 31, 2018	-0.036M
December 31, 2017	-0.028M
September 30, 2017	-0.023M
June 30, 2017	-0.125M
March 31, 2017	-0.091M
December 31, 2016	-0.121M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-0.443M

Minimum

Jun 2019

-0.014M

Maximum

Sep 2021

-0.1439M

Average

-0.067M

Median

Dec 2022

Cash from Investing (TTM) Benchmarks